High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis.

Ilkay Ergenc Pinar Gokcen Gupse Adali Haluk Tarik Kani Coskun Ozer Demirtas Feyza Gunduz Çiğdem Ataizi Çelikel Yusuf Yilmaz

Published in: Hepatology forum (2021)

Higher anti-HBc positivity was found in MAFLD patients with advanced fibrosis and cirrhosis compared to patients with early stage fibrosis. No relation was found between anti-HBc positivity and development of cirrhosis, HCC or other liver related complications.

Keyphrases

early stage
risk factors
liver fibrosis
fatty acid
sentinel lymph node
drug induced
neoadjuvant chemotherapy